Prostate cancer is the second leading cause of cancer deaths among men in the United States, and Michigan Medicine is opening a new clinic considered to be the first of its kind in the nation to deal with high-risk cases.
A clinic for men at high risk of prostate cancer with known genetic mutations is opening this month in hopes of providing state of the art care.
Dr. Todd Morgan is Associate Professor of Urology at the University of Michigan and says they will dealing with more aggressive cases of prostate cancer at the center, focusing on curing and preventing prostate cancer cases.
"Men who are more likely to develop aggressive prostate cancer, we want to find those cancers early to cure them and prevent death and suffering from prostate cancer. That's what we're all about," says Morgan.
The Michigan Medicine Prostate Cancer Risk Clinic will initially offer treatment for those identified with the prostate cancer mutations then gradually offer genetic counseling and screening.
Non-commercial, fact based reporting is made possible by your financial support. Make your donation to WEMU today to keep your community NPR station thriving.